Description

PharmaQo Fermaprovi contains 5 mg Mesterolone per oral tablet, intended for research use only. Mesterolone is a synthetic oral androgen under investigation for its androgen receptor agonist activity, potential support of endogenous testosterone production, and use in androgen-deficiency research models.

It is notable for its low anabolic activity and strong androgenic effects, making it a research focus for male fertility, mood, libido, and androgen replacement models.

Product Details:
Active Ingredient:

• Mesterolone (Proviron)

Concentration: 5 mg per tablet

Form: Oral tablets

Packaging: Typically provided in research packs (confirm pack size)

Pharmacokinetics:
Mesterolone has a half-life of ~12–13 hours, requiring multiple daily doses in research settings.

Usage Recommendations:

• Indications (Research Context): Investigational use in androgen receptor activity studies, male hypogonadism models, fertility and libido research (not approved for human use)

• Typical Dosage (Research Use): 25–75 mg per day, divided into 2–3 doses

• Monitoring: Androgen markers, lipid profile, liver function, hormonal balance

• Cycle/Duration: As per research protocol

Disclaimer:
This product is intended strictly for research and educational purposes. It is not for human consumption or therapeutic use. Not suitable for individuals under 18, pregnant or breastfeeding women, or those with medical risks. Always comply with local research laws and ethical standards.